Breaking News, Financial News

Financial Report: Sanofi

Generic competition, Brazil issue impact results

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sanofi 2Q Revenues: €8.0 billion (-10%) 2Q Earnings: €1.5 billion (-23%) YTD Revenues: €16.1 billion (-8%) YTD Earnings: €3.1 billion (-29%) Comments: Pharmaceutical sales were €6.7 billion in the quarter, down 7%, due to generic competition, EU austerity measures, and an adjustment of €122 million related to stocking issues in Brazil. Sales lost due to generic competition on main legacy products in the U.S. and EU were €481 million, with declining sales of Eloxatin, Lovenox, Plavix and Apr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters